Form 4: Arteris CEO Charles Janac Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Arteris CEO Charles Janac sold a total of 116,325 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.
Summary
- Arteris, Inc. CEO Charles Janac sold 60,584 shares of common stock on December 26, 2024, at a weighted average price of $10.4215 per share.
- The shares were sold in multiple transactions with prices ranging from $10.00 to $10.70.
- On December 27, 2024, Mr. Janac sold an additional 55,741 shares at a weighted average price of $10.2201 per share.
- These shares were sold in multiple transactions with prices ranging from $10.00 to $10.67.
- The sales were executed under a 10b5-1 trading plan adopted on February 27, 2024.
- Following these transactions, Mr. Janac directly owns 274,776 shares and indirectly owns 10,078,800 shares through Bayview Legacy, LLC, and 77,286 shares through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The document reports routine stock sales by the CEO under a pre-arranged plan, which is neither particularly positive nor negative.
Risks
- Sales by a company's CEO could be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors.
Comparison to Industry Standards
- Executive stock sales are a normal part of compensation and portfolio management for executives in publicly traded companies.
- The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading, and is used by many executives at similar companies.
- The reported sales are not unusual in terms of volume or price range compared to other similar transactions by executives at comparable companies.
Stakeholder Impact
- Shareholders may react to the news of the CEO selling shares, although the pre-arranged nature of the sales may mitigate concerns.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 12/26/2024 | Date of the first reported sale of 60,584 shares. |
| 12/27/2024 | Date of the second reported sale of 55,741 shares. |
| 12/30/2024 | Date the Form 4 was signed. |
Keywords
Arteris, Charles Janac, insider trading, 10b5-1 plan, stock sale, executive, share transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.